Geode Capital Management, LLC Co Diagnostics, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 321,275 shares of CODX stock, worth $244,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
321,275
Previous 317,380
1.23%
Holding current value
$244,169
Previous $396,000
1.26%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
4.28MCall Options Held
48.2KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.35 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny568KShares$431,4680.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$381,5390.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$207,4040.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA188KShares$142,5520.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $25.7M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...